Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 90 days matching "Pulmonary Arterial Hypertension"

PipelineRSSMay 11

Companies working on inhaled version of PAH treatment ralinepag

Two companies are working together to create a new way to take a PAH medicine. Instead of swallowing a pill, patients would inhale a dry powder that goes straight to the lungs. This gives people with pulmonary arterial hypertension another option for how they receive their treatment.

WHY IT MATTERSIf approved, inhaled ralinepag could offer PAH patients a non-invasive alternative to oral tablets, potentially improving drug delivery directly to affected lung tissue and reducing systemic side effects.
👁 Watch this spacepulmonary arterial hypertension

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases